162 related articles for article (PubMed ID: 31568784)
1. Cardioprotective effects of galectin-3 inhibition against ischemia/reperfusion injury.
Mo D; Tian W; Zhang HN; Feng YD; Sun Y; Quan W; Hao XW; Wang XY; Liu XX; Li C; Cao W; Liu WJ; Li XQ
Eur J Pharmacol; 2019 Nov; 863():172701. PubMed ID: 31568784
[TBL] [Abstract][Full Text] [Related]
2. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
Ibarrola J; Matilla L; Martínez-Martínez E; Gueret A; Fernández-Celis A; Henry JP; Nicol L; Jaisser F; Mulder P; Ouvrard-Pascaud A; López-Andrés N
Sci Rep; 2019 Jul; 9(1):9607. PubMed ID: 31270370
[TBL] [Abstract][Full Text] [Related]
3. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Ischemia Reperfusion Injury: Apoptotic, Inflammatory and Oxidative Stress Role of Galectin-3.
Al-Salam S; Hashmi S
Cell Physiol Biochem; 2018; 50(3):1123-1139. PubMed ID: 30355930
[TBL] [Abstract][Full Text] [Related]
5. Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Wang S; Li Y; Song X; Wang X; Zhao C; Chen A; Yang P
J Transl Med; 2015 Jul; 13():209. PubMed ID: 26136232
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
7. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion.
Li D; Liu M; Tao TQ; Song DD; Liu XH; Shi DZ
Cell Physiol Biochem; 2014; 34(4):1413-26. PubMed ID: 25301366
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury.
Yang Y; Duan W; Lin Y; Yi W; Liang Z; Yan J; Wang N; Deng C; Zhang S; Li Y; Chen W; Yu S; Yi D; Jin Z
Free Radic Biol Med; 2013 Dec; 65():667-679. PubMed ID: 23880291
[TBL] [Abstract][Full Text] [Related]
9. Penehyclidine hydrochloride preconditioning provides cardiac protection in a rat model of myocardial ischemia/reperfusion injury via the mechanism of mitochondrial dynamics mechanism.
Yang Y; Zhao L; Ma J
Eur J Pharmacol; 2017 Oct; 813():130-139. PubMed ID: 28755984
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury.
Ong SB; Subrayan S; Lim SY; Yellon DM; Davidson SM; Hausenloy DJ
Circulation; 2010 May; 121(18):2012-22. PubMed ID: 20421521
[TBL] [Abstract][Full Text] [Related]
11. β-Cryptoxanthin exerts greater cardioprotective effects on cardiac ischemia-reperfusion injury than astaxanthin by attenuating mitochondrial dysfunction in mice.
Pongkan W; Takatori O; Ni Y; Xu L; Nagata N; Chattipakorn SC; Usui S; Kaneko S; Takamura M; Sugiura M; Chattipakorn N; Ota T
Mol Nutr Food Res; 2017 Oct; 61(10):. PubMed ID: 28544535
[TBL] [Abstract][Full Text] [Related]
12. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
13. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA KCNQ1OT1/microRNA-204-5p/LGALS3 axis regulates myocardial ischemia/reperfusion injury in mice.
Rong J; Pan H; He J; Zhang Y; Hu Y; Wang C; Fu Q; Fan W; Zou Q; Zhang L; Tang Y; Peng X; Wang P; Xiang Y; Peng J; Liu Z; Zheng Z
Cell Signal; 2020 Feb; 66():109441. PubMed ID: 31644943
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 knock down inhibits cardiac ischemia-reperfusion injury through interacting with bcl-2 and modulating cell apoptosis.
Zhang M; Cheng K; Chen H; Tu J; Shen Y; Pang L; Wu W
Arch Biochem Biophys; 2020 Nov; 694():108602. PubMed ID: 32980351
[TBL] [Abstract][Full Text] [Related]
16. Nutritional Preconditioning of Apigenin Alleviates Myocardial Ischemia/Reperfusion Injury via the Mitochondrial Pathway Mediated by Notch1/Hes1.
Huang H; Lai S; Luo Y; Wan Q; Wu Q; Wan L; Qi W; Liu J
Oxid Med Cell Longev; 2019; 2019():7973098. PubMed ID: 31015891
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
[TBL] [Abstract][Full Text] [Related]
18. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TIMP3 Protects Against Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Apoptosis Through ROS/Mapks Pathway.
Liu H; Jing X; Dong A; Bai B; Wang H
Cell Physiol Biochem; 2017; 44(3):1011-1023. PubMed ID: 29179205
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Sun Y; Zhang Y; Yan M; Wu Y; Zheng X
Biol Pharm Bull; 2009 Sep; 32(9):1545-51. PubMed ID: 19721230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
